Related Experiment Video
Updated: Apr 17, 2026

Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis
Published on: December 18, 2019
Transcriptional Profiling of Laser Capture Microdissected Subpopulations of the Osteoblast Lineage Provides Insight
Paul Nioi1, Scott Taylor1, Rong Hu1
1Department of Comparative Biology and Safety Sciences, Amgen Inc., Thousand Oaks, CA, USA.
Abstract:
Sclerostin antibody (Scl-Ab) increases bone formation through a process dependent on the activation of canonical Wnt signaling, although the specific signaling in the osteoblast lineage in vivo is largely unknown. To gain insight into the signaling pathways acutely modulated by Scl-Ab, the transcriptional response of subpopulations of the osteoblast lineage was assessed by TaqMan and microarray analyses of mRNA isolated from laser capture microdissection (LCM)-enriched samples from the vertebrae of ovariectomized rats during the first week after Scl-Ab administration. Briefly, 6-month-old Sprague-Dawley rats were ovariectomized and, after 2 months, received a single dose of vehicle (VEH) or 100 mg/kg Scl-Ab (n = 20/group). Lumbar vertebrae were collected at 6, 24, 72, and 168 hours postdose and cryosectioned for LCM. Osteocytes were captured from bone matrix, and osteoblasts and lining cells were captured from bone surfaces based on fluorochrome labeling. mRNA was isolated, amplified, and profiled by TaqMan and microarray. Expression analysis revealed that Scl-Ab caused strikingly similar transcriptional profiles across all three cell types. Only 13 known canonical Wnt target genes, the majority with known functions in bone, showed a significant change in expression by microarray in response to Scl-Ab, with Wisp1 and Twist1 being the most responsive. Coincident with increased expression of Wnt target genes was the upregulation of numerous extracellular matrix (ECM) genes. The acute and progressive upregulation of ECM genes in lining cells supports their activation into matrix-producing osteoblasts, consistent with modeling-based bone formation. A similar transcriptional profile in osteocytes may indicate that Scl-Ab stimulates perilacunar/pericanalicular matrix deposition. Pathway analyses indicated that Scl-Ab regulated a limited number of genes related to cell cycle arrest and B-cell development. These data describe the acute downstream signaling in response to Scl-Ab in vivo and demonstrate selected canonical Wnt target gene activation associated with increased bone formation in all mature osteoblast subpopulations.
Insights
Sclerostin antibody (Scl-Ab) treatment activates Wnt signaling in osteoblasts, osteocytes, and lining cells, promoting bone formation by upregulating extracellular matrix genes. This study reveals Scl-Ab
Area of Science:
- Bone biology and regenerative medicine
- Molecular signaling pathways in osteogenesis
- Pharmacological modulation of bone metabolism
Background:
- Sclerostin antibody (Scl-Ab) treatment enhances bone formation via canonical Wnt signaling.
- The precise in vivo Wnt signaling activated by Scl-Ab in the osteoblast lineage remains unclear.
- Understanding these pathways is crucial for developing effective osteoporosis therapies.
Purpose of the Study:
- To investigate the acute transcriptional response to Scl-Ab in distinct osteoblast subpopulations.
- To identify specific Wnt target genes and downstream signaling pathways modulated by Scl-Ab in vivo.
- To elucidate the cellular mechanisms underlying Scl-Ab-induced bone formation.
Main Methods:
- Utilized laser capture microdissection (LCM) to isolate osteocytes, osteoblasts, and lining cells from rat vertebrae.
- Administered Scl-Ab or vehicle to ovariectomized rats and collected samples at various time points post-treatment.
- Performed TaqMan and microarray analyses to profile mRNA expression changes in response to Scl-Ab.
Main Results:
- Scl-Ab induced similar transcriptional profiles across osteocytes, osteoblasts, and lining cells.
- Upregulation of key Wnt target genes, including Wisp1 and Twist1, was observed.
- Increased expression of extracellular matrix (ECM) genes in lining cells suggests activation into matrix-producing osteoblasts.
Conclusions:
- Scl-Ab acutely activates canonical Wnt target genes in all mature osteoblast subpopulations.
- The observed transcriptional changes support Scl-Ab-mediated bone formation through osteoblast activation and matrix deposition.
- These findings provide insights into the in vivo molecular mechanisms of Scl-Ab action.

